Tarsons Products Limited
TARSONS · 543399 · Healthcare · Medical Equipment & Supplies
- Market cap
- Rs 1,617 Cr
- P/E
- No data: the source has not published this figure.
- P/B
- 2.55x
- 52W high / low
- Rs 375 / Rs 164.45
Our computed operating_margin (9.35%) diverges from BSE's own published figure (35.90%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (2.51%) diverges from BSE's own published figure (0.79%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
About Tarsons Products
Tarsons Products Limited is listed on the NSE under the symbol TARSONS and on the BSE under scrip code 543399. It is classified in the Healthcare sector, industry: Medical Equipment & Supplies. It is a constituent of BSE Healthcare. The company listed on 26 Nov 2021 and has a face value of Rs 2.
The latest available end-of-day price is Rs 303.95 (−0.21% on the day), for a market capitalisation of Rs 1,617 Cr. Price-to-book is 2.55x. The 52-week range is Rs 164.45 to Rs 375. The latest price is 66% of the way from the 52-week low to the 52-week high.
Against the 10-company comparison set from the official BSE basic industry Medical Equipment & Supplies, its market capitalisation is 1.0 times the peer median of Rs 1,617 Cr. The comparison set is chosen mechanically from the exchange classification; it is not a ranking.
Latest annual results
For FY26 (year ended 31 Mar 2026), Tarsons Products Limited reported revenue of Rs 423 Cr and net profit of Rs 14.3 Cr, with a net margin of 3.39% and earnings per share of Rs 2.69 (consolidated statements).
Year-on-year change: revenue +9.38%; net profit −51.89%; EPS −51.96%.
At the same date the balance sheet shows total assets of Rs 1,186 Cr, shareholders' equity of Rs 635 Cr, total debt of Rs 383 Cr, cash of Rs 23.2 Cr, a debt-to-equity ratio of 0.60 and operating cash flow of Rs 118 Cr.
On a trailing-twelve-month basis the filings add up to revenue of Rs 441 Cr, net income of Rs 11.1 Cr and a net margin of 2.51%.
Shareholding pattern
In the shareholding pattern for 30 Sept 2026, Tarsons Products Limited's ownership is split: promoters 47.30%; foreign institutional investors (FIIs) 0.55%; domestic institutional investors (DIIs) 0.61%; retail and other shareholders 51.54%.
Compared with the filing for 30 Jun 2026: promoter holding 0.00 percentage points; FII holding +0.39 percentage points; DII holding +0.51 percentage points.
The same filing lists reported promoter pledge of 0.00% and 80,867 shareholders on record.
Recent filings and corporate actions
78 BSE corporate announcements were filed by Tarsons Products Limited in the past twelve months; the most frequent category is "Company Update" (54). The most recent is "Intimation under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026." (Company Update), filed on 9 Oct 2026.
The disclosed corporate-action timeline lists 1 entries: dividend (1). The latest is a dividend (Final Dividend - Rs. - 2.0000) with ex-date 20 Sept 2024.
Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.
More
Peer comparison
Official BSE basic industry: Medical Equipment & Supplies. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Poly Medicure Limited | Rs 1,461.9 | Rs 14,818 Cr | Rs 2,109 Cr | Rs 313 Cr | 47.02x | 10.73% |
| Molbio Diagnostics Limited | Rs 1,302.6 | Rs 14,688 Cr | — | — | 88.19x | — |
| Sahajanand Medical Technologies Limited | Rs 476.55 | Rs 4,850 Cr | — | — | 71.45x | — |
| Fischer Medical Ventures Limited | Rs 25.93 | Rs 1,697 Cr | Rs 373 Cr | Rs 29.8 Cr | 10.80x | 8.25% |
| Tarsons Products LimitedThis company | Rs 303.95 | Rs 1,617 Cr | Rs 468 Cr | Rs 11.1 Cr | — | 1.75% |
| Laxmi Dental Limited | Rs 177.37 | Rs 975 Cr | Rs 296 Cr | Rs 30.9 Cr | 31.34x | 13.67% |
| Hemant Surgical Industries Ltd | Rs 585 | Rs 850 Cr | — | — | 46.68x | — |
| Fabtech Technologies Limited | Rs 122.21 | Rs 543 Cr | Rs 414 Cr | Rs 35.6 Cr | 14.34x | 8.11% |
| Prevest Denpro Ltd | Rs 380.15 | Rs 456 Cr | — | — | 22.27x | — |
| Nureca Limited | Rs 302.9 | Rs 289 Cr | Rs 160 Cr | Rs 4.3 Cr | 70.44x | 2.31% |
| Median | Rs 380.15 | Rs 1,617 Cr | Rs 373 Cr | Rs 29.8 Cr | 46.85x | 8.25% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Companies related to Tarsons Products
Same official industry (Medical Equipment & Supplies)
- Poly Medicure LimitedPOLYMED · Market cap Rs 14,818 Cr
- Molbio Diagnostics LimitedMOLBIO · Market cap Rs 14,688 Cr
- Sahajanand Medical Technologies LimitedSMT · Market cap Rs 4,850 Cr
- Fischer Medical Ventures LimitedFISCHER · Market cap Rs 1,697 Cr
- Laxmi Dental LimitedLAXMIDENTL · Market cap Rs 975 Cr
- Hemant Surgical Industries LtdINE0GYI01028 · Market cap Rs 850 Cr
- Fabtech Technologies LimitedFABTECH · Market cap Rs 543 Cr
- Prevest Denpro LtdINE0GAO01018 · Market cap Rs 456 Cr
Other Healthcare companies of a similar market capitalisation
- Syngene International LimitedSYNGENE · Market cap Rs 16,091 Cr
- Vijaya Diagnostic Centre LimitedVIJAYA · Market cap Rs 15,066 Cr
- Jubilant Pharmova LimitedJUBLPHARMA · Market cap Rs 14,947 Cr
- Indegene LimitedINDGN · Market cap Rs 14,272 Cr
- Natco Pharma LimitedNATCOPHARM · Market cap Rs 14,097 Cr
- Concord Biotech LimitedCONCORDBIO · Market cap Rs 12,874 Cr
- Rainbow Childrens Medicare LimitedRAINBOW · Market cap Rs 12,155 Cr
- Blue Jet Healthcare LimitedBLUEJET · Market cap Rs 8,735 Cr
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.